BODISEN BIOTECH, INC: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $8.1M
- Net Income/Loss (FY2012)
- -$16.4M
- Total Assets (FY2012)
- $22.7M
- Total Equity (FY2012)
- $19.9M
- Cash Flows from Operating Activities (FY2012)
- -$2.1M
Source: BODISEN BIOTECH, INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
